{"name":"Speciality European Pharma Limited","slug":"speciality-european-pharma-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Goserelin plus Bicalutamide","genericName":"Goserelin plus Bicalutamide","slug":"goserelin-plus-bicalutamide","indication":"Metastatic prostate cancer","status":"phase_3"}]}],"pipeline":[{"name":"Goserelin plus Bicalutamide","genericName":"Goserelin plus Bicalutamide","slug":"goserelin-plus-bicalutamide","phase":"phase_3","mechanism":"Goserelin suppresses testosterone production via GnRH receptor agonism, while bicalutamide blocks androgen receptor signaling, providing dual hormonal suppression for androgen-dependent cancers.","indications":["Metastatic prostate cancer","Locally advanced prostate cancer","High-risk localized prostate cancer (neoadjuvant/adjuvant to radiotherapy)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQOGcyQTB6NVpieTRWLXYtZWZRbmFMSXhON1d5alUxc1dCdTFnZVhBWlZrOG5XVnVwQUxaVmdFVEU0YjFXbklVOXA0NWNzNkx4MlZUR3d4ajFudGIwS3pud05pZ0xjQmFqTm90cktua3RaeUY5Wlp2RmVnY1YwS3RVdU5La19BaFRjenJ3TXFhYUJJSmZidHZqeGVISEZHcGs?oc=5","date":"2026-04-07","type":"pipeline","source":"Manufacturing Chemist","summary":"Lupin completes acquisition of VISUfarma from GHO to expand ophthalmology portfolio - Manufacturing Chemist","headline":"Lupin completes acquisition of VISUfarma from GHO to expand ophthalmology portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOc3NndG50MVF0UW1LcWVNNkZueUNlMUJlM3NwMENrbzBSQU96VElXYjBhYkVmcERvamlNMGxzUWZ4Z3FYWGFyM0pYQjRyUmZPXzlYMTlDYXV1SmpDX1ZTSV9OcnhBYVI2cjNzNVRaUE9nLWRqbzlSVk9jX1RtTlVydW96UWJ4akZSaEdUUmpCUTdiNy1xWjV1aVIzTWdVUXJNRGFubG1qeXZ5b1pHc3hNdmVCZ9IBuAFBVV95cUxOcWNxV3oydGlNRlJ4dkVGZ3dTNEMtQS1YR3FwbFV0TVdkOUJlNEVoZXlYeXVFZ2J5Sl9RbFZJdlMxTS0xdG41NEw5MV9aQXBGRld1Tk16eUJaR1lhYmVMS1g0cEFfZkVacmJWV2k3aGh6SHRUaHZTVEdTaENXZ2lQdTBwRzZHUXJYR1dDeDBaZEZTYUNyNXNyOXRybXRaQm1VVU9vVDByT3hRSmc4R1RfemphSFAwU1hs?oc=5","date":"2026-04-02","type":"pipeline","source":"Devdiscourse","summary":"Lupin Expands European Footprint with VISUfarma Acquisition - Devdiscourse","headline":"Lupin Expands European Footprint with VISUfarma Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPSHhQbXNSUnlBMlZBUGQ1b2VnY0RUYU13MlNVNHU2ZkdnT1dqbGhOYU5rZ2dDNkdMcGMzVkVXOWxkVnR2S3hVYTFsWWYxSl9jcTBxQnhKc2JFNkNpVGZ5VXJZN05ub3g2YzRWWFpCempPX1lvcmhtbWtXZGxBc2MwYS1WOWVIcHVRR2NSSkVHRi05QmlYSTlYcTNGbnBtVkZvS0gyZTNXaGdUNk9kOTVkUV9HTEc3OGpUc3hfSDI1NA?oc=5","date":"2026-03-25","type":"pipeline","source":"AD HOC NEWS","summary":"Recordati S.p.A. stock faces pressure amid rare disease drug pipeline scrutiny and European pharma s - AD HOC NEWS","headline":"Recordati S.p.A. stock faces pressure amid rare disease drug pipeline scrutiny and European pharma s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNdkstZTJXZVFmdWZTV1FLbXhtVThWTjRsS1pqd0JqN3JUQTdHZDFGOFhrNTZIQ0hiMHF6cXpyWUVieEF5eWhhYm5VUzBEemstdDg2dEtETnE1bEN1LTVfM2lRdWZzY2MzaHVUMzZjX2h5SXNDaTBwaURYbVBKWkRhYS1qczNWcFZ6cVY2NEdudVhoM1NiVUJ0OU1n?oc=5","date":"2026-02-02","type":"pipeline","source":"Bain & Company","summary":"Accelerating Growth and Innovation in European Mid-Sized Pharma - Bain & Company","headline":"Accelerating Growth and Innovation in European Mid-Sized Pharma - Bain & Company","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-27","type":"pipeline","source":"Business Standard","summary":"OneSource Specialty Pharma Ltd leads losers in 'A' group - Business Standard","headline":"OneSource Specialty Pharma Ltd leads losers in 'A' group","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-27","type":"pipeline","source":"Moneycontrol.com","summary":"India-EU FTA to boost pharma, chemicals trade, Indian medical professionals' credentials to gain... - Moneycontrol.com","headline":"India-EU FTA to boost pharma, chemicals trade, Indian medical professionals' credentials to gain...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNcWdTbjdidXVlOXA3SUxidE1WakRVWXhHYktYQVJCSVZ5TzFNeVljbjhlbTR3WEhpNWhDZTZTSV9PVTR4OEVrMFgtbjJEaUlfZGEtcmZIeDNLTGt0V2JWTW9IcFROSlU5bWdmRldMLVF2LTktZXJTNzBBdFRKUVZGMUhB?oc=5","date":"2025-12-19","type":"deal","source":"pehub.com","summary":"PE dives into specialty pharmacy and pharmaceutical sectors: 6 deals - pehub.com","headline":"PE dives into specialty pharmacy and pharmaceutical sectors: 6 deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOTVpCY203VDg4UzVjWUNPNGpLdnZLVjBQZlpmc0s3NkZPWGFiZWpCTE13WTU3bEdkalBvMDV0VVh0Ry1XUFBxbUJoOG5ZVnByR1g1d2ttaVFTQ3JnM2pSZ29uWmVIUnhpSlk4VW90RGk1aXpVNTQwVF9xM3drSmdGTE5fZTI1TjBINFhWUUtlU1pUcFNpRmlUMDU1aE9xVXJaWVJidHpCbEo1c1NiOEtTRmNYSFcyWUdRaUxrUzNuZGU1YnJvVWNTMXllZFdpbERWbDdUWFBKamVkM0otcm02SldraVlhZWM2V01TMExmSE9tOHNkY2FSMlVRTjV1TEdu?oc=5","date":"2025-12-17","type":"pipeline","source":"PR Newswire","summary":"Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology - PR Newswire","headline":"Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOOEFRclVOUmtfOHJYb1JMNE5mZnNWbTdvN3VZVlAyUU1oU0NXcGUwdVptMVJ5NUxab0NmSHZiZHRCWndpblZOOEsyNmRwTEhGUnhfZHV3YkNhejhOdXBmTVJ1LUZwX1VwVVZ2SVRFY1k1a0J3TUhRb2dzZzlhckl1Snln?oc=5","date":"2025-11-04","type":"pipeline","source":"Fortune Business Insights","summary":"Europe Pharmaceuticals Market Size, Share | Growth [2032] - Fortune Business Insights","headline":"Europe Pharmaceuticals Market Size, Share | Growth [2032]","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNdHV2UThoUmg1MWl1MVJSbkdUclZrcEdwdk1fTHBOSmNXWUVySXpjM1Z2YWNvWjBRX0h6Zk1BYkhKekFsRmtwV3pOMVd6b2U5Z0JqWEZNTzVuT2VuRmtUemJIZmdtbDVzNDFYS3o3dmlNLUMtQUFKY0pwZGZwNXFwUWZmX2U1aS1paXhYa3hSelBBOUxCSHpsUkt6bnJPNFJRVUlSVGZUX3dDZTR2ZVF3S2ZwTXgzMWFJVFpPWXcxOA?oc=5","date":"2025-09-30","type":"deal","source":"BioPharma APAC","summary":"Lupin To Acquire VISUfarma To Expand European Specialty Ophthalmology Presence - BioPharma APAC","headline":"Lupin To Acquire VISUfarma To Expand European Specialty Ophthalmology Presence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPT2JsNmw0UUxlaGF0TU5NUEszYTJyMzhlLXVZZmdWeko0bnF1cXRvNXVfb0dYQ1ZGZWZBZUJhUFdwWUZsYjV5NnRsTDZQM25HeFdVZHlwUzZyQU9SeEMxSE5ON1l1Qi00Sl9VYUlybzZIdG1FZlExSmtiel9YSlNQWm9aZHVqR2NsVmEtY3pIX1VwajZyVXh4eFdrR2hHUUFSM1JHOG1pTHdZRjVZcWR3eE1FQ1diMklQblhuZnVEcmdBNUhNOUEzbXY4OFc1ckc1dTNDcHU3TW9rRmFQTTJSZWNB?oc=5","date":"2025-09-29","type":"pipeline","source":"BioSpace","summary":"Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital - BioSpace","headline":"Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOdW1WcklLQ1hHV0NfUm5Qdl9nb3VVMFBmRlc3VkRJaW8xLTI5dHBtRHJpeURHUUhNYUtFYW14a2dnRHA2VnFXQ1dDaXlJbjNCci1Ocjdra0xXcGMzcDF5X0ZyRlY1ZWRPeVpIN0dSQ0pJZ1QxRVZCTVJIODhvMWxXcEltLVFJQzVseVhfeG4wcHd1Ull5RE82ZnAyR09UMXEzMXc?oc=5","date":"2025-07-01","type":"deal","source":"Ingredients Network","summary":"Sudeep Pharma Limited Acquires Nutrition Supplies Services (NSS), Expands Global Presence in Infant Formula and Clinical Nutrition - Ingredients Network","headline":"Sudeep Pharma Limited Acquires Nutrition Supplies Services (NSS), Expands Global Presence in Infant Formula and Clinical","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}